Replication/NN
of/IN
the/DT
Association/NN
of/IN
the/DT
6q22.31c/NN
Locus/NN
near/JJ
GJA1/NN
with/IN
Pulse/JJ
Rate/NN
in/IN
the/DT
Korean/JJ
Population/NN
./.
====================
Pulse/JJ
rate/NN
is/VBZ
known/VBN
to/TO
be/VB
related/JJ
to/TO
diverse/JJ
phenotypes/NNS
,/,
such/JJ
as/IN
cardiovascular/JJ
diseases/NNS
,/,
lifespan/JJ
,/,
arrhythmia/NN
,/,
hypertension/NN
,/,
lipids/NNS
,/,
diabetes/VBZ
,/,
and/CC
menopause/JJ
./.
====================
We/PRP
have/VBP
reported/VBN
two/CD
genomewide/JJ
significant/JJ
genetic/JJ
loci/NNS
responsible/JJ
for/IN
the/DT
variation/NN
in/IN
pulse/NN
rate/NN
as/IN
a/DT
part/NN
of/IN
the/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
project/VBP
,/,
the/DT
genomewide/NN
association/NN
study/NN
(/(
GWAS/NN
)/)
that/WDT
was/VBD
conducted/VBN
with/IN
352,228/CD
single/JJ
nucleoride/JJ
polymorphisms/NNS
typed/VBN
in/IN
8,842/CD
subjects/NNS
in/IN
the/DT
Korean/JJ
population/NN
./.
====================
GJA1/NN
was/VBD
implied/VBN
as/IN
a/DT
functionally/RB
causal/JJ
gene/NN
for/IN
pulse/NN
rate/NN
from/IN
the/DT
KARE/NN
study/NN
,/,
but/CC
lacked/VBD
evidence/NN
of/IN
replication/NN
./.
====================
To/TO
re-evaluate/VB
the/DT
association/NN
of/IN
a/DT
locus/NN
near/JJ
GJA1/NN
with/IN
pulse/NN
rate/NN
,/,
we/PRP
looked/VBD
up/IN
this/DT
signal/NN
in/IN
another/DT
GWAS/NN
conducted/VBN
in/IN
a/DT
Health/NN
Examinee-shared/JJ
cohort/NN
of/IN
3,703/CD
samples/NNS
./.
====================
Not/RB
only/RB
we/PRP
were/VBD
able/JJ
to/TO
confirm/VB
two/CD
pulse/JJ
rate/NN
loci/NNS
(/(
1q32.2a/NN
near/JJ
CD46/NN
and/CC
6q22.13c/JJ
near/JJ
LOCL644502/NN
)/)
identified/VBD
in/IN
the/DT
KARE/NN
GWAS/NN
,/,
we/PRP
also/RB
replicated/VBD
a/DT
locus/NN
(/(
6q22.31c/NN
)/)
near/JJ
GJA1/NN
by/IN
the/DT
lookup/NN
in/IN
the/DT
Health/NN
Examinee/NNP
GWAS/NN
./.
====================
Considering/VBG
that/DT
the/DT
GJA1-encoded/JJ
protein/NN
is/VBZ
a/DT
major/JJ
component/NN
of/IN
cardiac/JJ
gap/NN
junctions/NNS
,/,
a/DT
functional/JJ
study/NN
might/MD
be/VB
necessary/JJ
to/TO
validate/VB
its/PRP$
genuine/JJ
molecular/JJ
biological/JJ
role/NN
in/IN
the/DT
synchronized/JJ
contraction/NN
of/IN
the/DT
heart/NN
./.
====================
Pulse/JJ
rate/NN
,/,
also/RB
called/VBN
heart/NN
rate/NN
,/,
is/VBZ
the/DT
number/NN
of/IN
heartbeats/NNS
per/FW
unit/NN
of/IN
time/NN
,/,
commonly/RB
used/VBN
as/IN
beats/NNS
per/FW
minute/JJ
(/(
BPM/NN
)/)
./.
====================
Pulse/JJ
rate/NN
is/VBZ
varied/VBN
in/IN
accordance/NN
with/IN
the/DT
body/NN
's/POS
need/NN
for/IN
oxygen/NN
changes/NNS
,/,
such/JJ
as/IN
during/IN
exercise/NN
or/CC
sleep/JJ
./.
====================
Since/IN
various/JJ
health-related/JJ
phenotypes/NNS
are/VBP
closely/RB
correlated/VBD
with/IN
pulse/NN
rate/NN
[/(
1-3/CD
]/)
,/,
measuring/VBG
pulse/NN
rate/NN
is/VBZ
commonly/RB
used/VBN
for/IN
diagnosing/VBG
and/CC
accessing/VBG
medical/JJ
conditions/NNS
./.
====================
Pulse/JJ
rate/NN
is/VBZ
known/VBN
to/TO
be/VB
positively/RB
correlated/VBD
with/IN
triglycerides/NNS
and/CC
negatively/RB
correlated/VBD
with/IN
high-density/JJ
lipoprotein/NN
cholesterol/NN
[/(
3/CD
]/)
./.
====================
Numerous/JJ
studies/NNS
have/VBP
reported/VBN
an/DT
association/NN
between/IN
heart/NN
rate/NN
and/CC
total/JJ
and/or/CC
cardiovascular/JJ
mortality/NN
[/(
1/CD
]/)
./.
====================
Metabolic/JJ
syndrome/NN
is/VBZ
associated/VBN
with/IN
poor/JJ
exercise/NN
capacity/NN
and/CC
poor/JJ
heart/NN
rate/NN
recovery/NN
in/IN
patients/NNS
who/WP
have/VBP
coronary/JJ
disease/NN
[/(
4/CD
]/)
./.
====================
Moreover/RB
,/,
high/JJ
pulse/NN
rate/NN
is/VBZ
negatively/RB
correlated/VBD
with/IN
lifespan/JJ
in/IN
mammals/NNS
,/,
including/VBG
humans/NNS
[/(
2/CD
]/)
./.
====================
Despite/IN
the/DT
importance/NN
of/IN
pulse/NN
rate/NN
as/IN
a/DT
risk/NN
factor/NN
for/IN
various/JJ
diseases/NNS
,/,
however/RB
,/,
few/JJ
genes/NNS
are/VBP
known/VBN
to/TO
be/VB
associated/VBN
with/IN
pulse/NN
rate/NN
,/,
and/CC
the/DT
underlying/VBG
mechanism/NN
for/IN
pulse/NN
rate/NN
remains/VBZ
unraveled/JJ
./.
====================
We/PRP
previously/RB
reported/VBD
pulse/NN
rate-associated/JJ
loci/NNS
from/IN
the/DT
Korea/NN
Association/NN
Resource/NN
(/(
KARE/NN
)/)
genomewide/NN
association/NN
study/NN
(/(
GWAS/NN
)/)
,/,
comprising/VBG
8,842/CD
samples/NNS
in/IN
the/DT
Korean/JJ
population/NN
[/(
5/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
extended/VBD
the/DT
previous/JJ
study/NN
and/CC
reexamined/VBD
the/DT
relevance/NN
of/IN
pulse/NN
rate-associated/JJ
single-nucleotide/JJ
polymorphisms/NNS
(/(
SNPs/NNS
)/)
from/IN
an/DT
additional/JJ
GWAS/NN
of/IN
3,703/CD
Korean/JJ
samples/NNS
./.
====================
Subjects/NNS
====================
In/IN
the/DT
discovery/NN
stage/NN
,/,
the/DT
association/NN
results/NNS
for/IN
pulse/NN
rate/NN
were/VBD
obtained/VBN
from/IN
the/DT
KARE/NN
study/NN
./.
====================
The/DT
information/NN
for/IN
subjects/NNS
of/IN
the/DT
KARE/NN
GWAS/NN
is/VBZ
described/VBN
elsewhere/VBP
[/(
5/CD
]/)
./.
====================
Subjects/NNS
for/IN
the/DT
replication/NN
stage/NN
were/VBD
recruited/VBN
from/IN
the/DT
Health/NN
Examinee/NN
cohorts/NNS
,/,
called/VBN
HEXA-shared/JJ
cohorts/NNS
./.
====================
The/DT
standardized/VBN
examinations/NNS
that/DT
were/VBD
applied/VBN
in/IN
this/DT
survey/NN
included/VBD
4,302/CD
participants/NNS
aged/JJ
40/CD
to/TO
70/CD
years/NNS
./.
====================
The/DT
characteristics/NNS
of/IN
the/DT
cohorts/NNS
are/VBP
described/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
measurement/NN
of/IN
pulse/NN
rate/NN
====================
Pulse/JJ
rate/NN
is/VBZ
the/DT
frequency/NN
of/IN
the/DT
heart/NN
beat/NN
(/(
BPM/NN
)/)
./.
====================
Pulse/JJ
rate/NN
of/IN
KARE/NN
was/VBD
measured/VBN
3/CD
times/NNS
while/IN
the/DT
participant/JJ
was/VBD
lying/VBG
down/RB
,/,
and/CC
the/DT
average/JJ
value/NN
was/VBD
used/VBN
for/IN
the/DT
analysis/NN
(/(
before/IN
the/DT
first/JJ
measurement/NN
,/,
participants/NNS
rested/VBD
for/IN
5/CD
min/NN
,/,
and/CC
3/CD
measurements/NNS
were/VBD
taken/VBN
at/IN
least/JJS
30/CD
s/NNS
apart/NN
)/)
./.
====================
In/IN
HEXA-shared/JJ
cohorts/NNS
,/,
the/DT
first/JJ
measurement/NN
of/IN
the/DT
participants/NNS
,/,
who/WP
rested/VBD
for/IN
5/CD
min/NN
,/,
was/VBD
used/VBN
./.
====================
Genotyping/VBG
and/CC
quality/NN
control/NN
====================
The/DT
methods/NNS
for/IN
genotyping/VBG
and/CC
quality/NN
control/NN
for/IN
the/DT
KARE/NN
GWAS/NN
have/VBP
been/VBN
described/VBN
elsewhere/RB
[/(
5/CD
]/)
./.
====================
For/IN
the/DT
HEXA/NN
GWAS/NN
,/,
genomic/JJ
DNA/NN
was/VBD
extracted/VBN
from/IN
4,302/CD
participants/NNS
from/IN
an/DT
urban/JJ
cohort/NN
and/CC
genotyped/VBD
with/IN
Affymetrix/JJ
Genome-Wide/NN
Human/JJ
SNP/NN
array/NN
6.0/CD
(/(
Affymetrix/JJ
,/,
Inc./NNP
,/,
Santa/NN
Clara/NN
,/,
CA/NNP
,/,
USA/NNP
)/)
./.
====================
From/IN
4,302/CD
genotyped/VBD
samples/NNS
,/,
we/PRP
excluded/VBD
samples/NNS
with/IN
a/DT
low/JJ
call/JJ
rate/RB
(/(
≥/NNP
95/CD
%/NN
,/,
n/NN
=/JJ
443/CD
)/)
,/,
high/JJ
heterozygosity/NN
(/(
n/NN
=/JJ
25/CD
)/)
,/,
outliers/VBZ
(/(
n/NN
=/JJ
26/CD
)/)
,/,
and/CC
gender/IN
inconsistencies/VBZ
(/(
n/NN
=/JJ
8/CD
)/)
,/,
and/CC
those/DT
obtained/VBN
from/IN
individuals/NNS
who/WP
had/VBD
developed/VBN
any/DT
kind/JJ
of/IN
cancer/NN
(/(
n/NN
=/JJ
61/CD
)/)
were/VBD
excluded/VBN
from/IN
subsequent/JJ
analyses/NNS
,/,
along/IN
with/IN
related/JJ
or/CC
identical/JJ
individuals/NNS
whose/WP$
computed/JJ
average/RB
pairwise/JJ
identity-by-state/VBP
value/NN
was/VBD
higher/JJR
than/IN
that/DT
estimated/VBN
from/IN
cryptic/JJ
first-degree/JJ
relatives/VBZ
of/IN
samples/NNS
(/(
n/NN
=/JJ
33/CD
)/)
./.
====================
SNP/NN
markers/NNS
with/IN
a/DT
high/JJ
missing/VBG
genotype/NN
rate/NN
(/(
>/JJR
5/CD
%/NN
)/)
,/,
minor/JJ
allele/NN
frequency/NN
(/(
MAF/NN
)/)
(/(
</JJR
0.01/CD
)/)
,/,
and/CC
significant/JJ
deviation/NN
from/IN
Hardy-Weinberg/JJ
equilibrium/NN
(/(
p/NN
</JJR
1/CD
×/NN
10-6/CD
)/)
were/VBD
excluded/VBN
,/,
leaving/VBG
a/DT
total/JJ
of/IN
627,659/CD
markers/NNS
to/TO
be/VB
examined/VBN
in/IN
3,703/CD
individuals/NNS
./.
====================
Statistical/JJ
analysis/NN
====================
Association/NN
analyses/NNS
were/VBD
performed/VBN
using/VBG
PLINK/NN
(/(
http/NN
:/:
//pngu.mgh.harvared.edu/~purcell/plink//JJ
)/)
[/(
6/CD
]/)
,/,
SAS/NN
version/NN
9.2/CD
(/(
SAS/NN
institute/JJ
Inc./NNP
,/,
Cary/NN
,/,
NC/NN
,/,
USA/NNP
)/)
,/,
and/CC
R/NN
statistics/NNS
package/NN
(/(
version/NN
2.7.1/CD
)/)
(/(
http/NN
:/:
//r-project.org//JJ
)/)
./.
====================
The/DT
SNP/NN
association/NN
for/IN
pulse/NN
rate/NN
was/VBD
tested/VBN
by/IN
linear/JJ
regression/NN
analysis/NN
with/IN
an/DT
additive/JJ
model/NN
,/,
adjusting/VBG
for/IN
age/NN
,/,
sex/NN
,/,
and/CC
recruitment/NN
area/NN
./.
====================
The/DT
KARE/NN
GWAS/NN
and/CC
replication/NN
GWAS/NN
were/VBD
combined/VBN
by/IN
an/DT
inverse-variance/NN
meta-analysis/NN
method/NN
,/,
assuming/VBG
fixed/JJ
effects/NNS
,/,
with/IN
Cochran/NN
's/POS
Q/NN
test/NN
used/VBN
to/TO
assess/VB
between-study/IN
heterogeneity/NN
[/(
7/CD
]/)
./.
====================
Meta-analysis/NN
calculations/NNS
were/VBD
performed/VBN
using/VBG
METAL/NN
(/(
http/NN
:/:
//www.sph.umich.edu/csg/abecasis/Metal/JJ
)/)
in/IN
the/DT
R/NN
program/NN
(/(
version/NN
2.7.1/CD
)/)
./.
====================
The/DT
discovery/NN
GWAS/NN
for/IN
pulse/NN
rate/NN
included/VBD
352,225/CD
SNPs/NNS
profiled/VBD
with/IN
Affymetrix/JJ
Genome-Wide/NN
human/JJ
SNP/NN
array/NN
5.0/CD
in/IN
8,842/CD
individuals/NNS
from/IN
the/DT
Ansung/JJ
and/CC
Ansan/NN
cohorts/NNS
as/IN
described/VBN
previously/RB
[/(
5/CD
]/)
./.
====================
Characteristics/NNS
of/IN
the/DT
study/NN
,/,
including/VBG
age/NN
,/,
sex/NN
,/,
and/CC
trait/VBP
summaries/VBZ
,/,
are/VBP
presented/VBN
in/IN
Table/JJ
1/CD
./.
====================
The/DT
association/NN
analysis/NN
identified/VBD
several/JJ
genomic/JJ
locations/NNS
as/IN
potentially/RB
associated/VBN
with/IN
pulse/NN
rate/NN
./.
====================
Unlike/IN
the/DT
previous/JJ
GWAS/NN
[/(
5/CD
]/)
,/,
we/PRP
did/VBD
not/RB
apply/RB
a/DT
threshold/JJ
with/IN
a/DT
p/NN
</JJR
0.01/CD
in/IN
both/DT
Ansung/JJ
and/CC
Ansan/JJ
cohort/JJ
in/IN
addition/NN
to/TO
a/DT
combined/JJ
p/NN
</JJR
1/CD
×/NN
10-5/CD
for/IN
the/DT
SNP/NN
selection/NN
for/IN
the/DT
replication/NN
study/NN
so/RB
that/IN
we/PRP
could/MD
include/VB
more/RBR
promising/VBG
SNPs/NNS
for/IN
their/PRP$
association/NN
with/IN
pulse/NN
rate/NN
./.
====================
We/PRP
observed/VBD
61/CD
significant/JJ
SNPs/NNS
by/IN
applying/VBG
only/RB
a/DT
threshold/JJ
with/IN
a/DT
combined/JJ
p/NN
</JJR
1/CD
×/NN
10-5/CD
./.
====================
After/IN
excluding/VBG
SNPs/NNS
by/IN
cluster/NN
plot/NN
inspection/NN
and/CC
removing/VBG
singletons/NNS
,/,
3/CD
independent/JJ
SNPs/NNS
(/(
that/DT
is/VBZ
,/,
with/IN
pairwise/JJ
linkage/NN
disequilibrium/NN
statistics/NNS
r2/NN
</JJR
0.2/CD
and/CC
MAF/NN
≥/CD
0.05/CD
within/IN
a/DT
500-kb/JJ
window/IN
of/IN
the/DT
genomic/JJ
region/NN
)/)
were/VBD
finally/RB
chosen/NN
to/TO
validate/VB
in/IN
the/DT
independent/JJ
population/NN
-/:
i.e./FW
,/,
the/DT
HEXA/NN
cohort/JJ
,/,
comprising/VBG
3,703/CD
individuals/NNS
./.
====================
In/IN
the/DT
replication/NN
study/NN
,/,
all/DT
3/CD
SNPs/NNS
were/VBD
confirmed/VBN
for/IN
their/PRP$
association/NN
with/IN
pulse/NN
rate/NN
at/IN
a/DT
p/NN
</JJR
0.05/CD
(/(
Table/JJ
2/CD
)/)
./.
====================
The/DT
first/JJ
pulse/NN
rate/NN
signal/NN
located/JJ
to/TO
1q32.2a/NN
(/(
rs12731740/CD
,/,
MAF/NN
=/JJ
0.103/CD
,/,
poverall/DT
=/JJ
2.20/CD
×/CD
10-8/CD
)/)
./.
====================
Three/CD
genes/NNS
,/,
such/JJ
as/IN
CD46/NN
,/,
Clorf132/NN
,/,
and/CC
CD34/NN
,/,
appear/VBP
near/JJ
this/DT
locus/NN
[/(
5/CD
]/)
./.
====================
The/DT
physiological/JJ
relevance/NN
of/IN
the/DT
3/CD
genes/NNS
in/IN
relation/NN
to/TO
pulse/VB
rate/NN
is/VBZ
not/RB
clear/JJ
[/(
8/CD
,/,
9/CD
]/)
./.
====================
Thus/RB
,/,
fine/JJ
mapping/NN
surrounding/VBG
this/DT
locus/NN
by/IN
targeted/VBN
resequencing/VBG
is/VBZ
highly/RB
recommended/VBN
to/TO
discover/JJ
the/DT
causal/JJ
variants/NNS
for/IN
pulse/NN
rate/NN
./.
====================
The/DT
second/JJ
pulse/NN
rate/NN
SNP/NN
is/VBZ
rs12110693/NN
(/(
MAF/NN
=/JJ
0.494/CD
,/,
poverall/DT
=/JJ
1.10/CD
×/CD
10-8/CD
)/)
on/IN
6q22.31c/NN
./.
====================
The/DT
only/RB
gene/NN
located/JJ
near/JJ
this/DT
SNP/NN
is/VBZ
LOC644502/NN
,/,
which/WDT
has/VBZ
no/DT
known/JJ
function/NN
./.
====================
The/DT
third/JJ
locus/NN
associated/VBN
with/IN
pulse/NN
rate/NN
is/VBZ
at/IN
6q22.31c/NN
(/(
rs2892767/NN
,/,
MAF/NN
=/JJ
0.261/CD
,/,
poverall/DT
=/JJ
2.50/CD
×/CD
10-7/CD
)/)
./.
====================
This/DT
locus/NN
is/VBZ
near/JJ
GJA1/NN
(/(
Gap/NNP
junction/NN
protein/NN
,/,
alpha/NN
1/CD
,/,
43/CD
kDa/NN
)/)
,/,
which/WDT
is/VBZ
a/DT
member/NN
of/IN
the/DT
connexin/NN
gene/NN
family/NN
./.
====================
The/DT
protein/NN
encoded/VBN
by/IN
GJA1/NN
is/VBZ
a/DT
component/NN
of/IN
gap/NN
junctions/NNS
,/,
which/WDT
are/VBP
intercellular/JJ
channels/NNS
that/DT
provide/VBP
a/DT
route/JJ
for/IN
the/DT
diffusion/NN
of/IN
low-molecular-weight/JJ
materials/NNS
from/IN
cell/NN
to/TO
cell/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
performed/VBD
a/DT
genomewide/NN
scan/NN
for/IN
pulse/NN
rate/NN
and/CC
identified/VBD
3/CD
loci/NNS
accounting/VBG
for/IN
the/DT
variation/NN
in/IN
pulse/NN
rate/NN
./.
====================
Two/CD
of/IN
3/CD
loci/NNS
were/VBD
previously/RB
reported/VBD
and/CC
replicated/VBD
once/RB
again/RB
in/IN
an/DT
independent/JJ
HEXA-shared/JJ
cohort/NN
./.
====================
The/DT
other/JJ
one/CD
(/(
rs2892767/NN
)/)
near/JJ
GJA1/NN
was/VBD
previously/RB
implicated/VBN
for/IN
its/PRP$
association/NN
with/IN
pulse/NN
rate/NN
but/CC
was/VBD
not/RB
chosen/NN
for/IN
the/DT
replication/NN
study/NN
,/,
since/IN
the/DT
SNP/NN
did/VBD
not/RB
meet/VB
the/DT
selection/NN
criteria/NNS
in/IN
the/DT
discovery/NN
stage/NN
[/(
5/CD
]/)
./.
====================
In/IN
the/DT
present/JJ
study/NN
,/,
SNP/NN
rs2892767/NN
near/JJ
GJA1/NN
was/VBD
taken/VBN
forward/IN
to/TO
the/DT
replication/NN
study/NN
using/VBG
the/DT
independent/JJ
dataset/NN
from/IN
the/DT
HEXA-shared/JJ
cohort/NN
and/CC
was/VBD
nicely/RB
confirmed/VBD
for/IN
its/PRP$
association/NN
with/IN
pulse/NN
rate/NN
./.
====================
Two/CD
SNPs/NNS
,/,
rs2892767/NN
near/JJ
GJA1/NN
and/CC
rs12110693/NN
near/JJ
LOC644502/NN
,/,
are/VBP
408/CD
kb/NN
apart/VBP
from/IN
each/DT
other/JJ
and/CC
are/VBP
located/JJ
in/IN
a/DT
separate/JJ
LD/NN
,/,
indicating/VBG
that/IN
both/CC
are/VBP
independent/JJ
SNPs/NNS
./.
====================
The/DT
independence/NN
between/IN
both/CC
SNPs/NNS
was/VBD
further/RBR
tested/VBN
by/IN
conditional/JJ
analyses/NNS
./.
====================
We/PRP
performed/VBD
multiple/JJ
linear/JJ
regression/NN
analyses/NNS
,/,
conditioning/VBG
the/DT
SNPs/NNS
to/TO
each/DT
other/JJ
to/TO
find/VB
a/DT
significantly/RB
stronger/JJR
proxy/NN
for/IN
pulse/NN
rate/NN
./.
====================
However/RB
,/,
no/DT
dramatic/JJ
decrease/NN
in/IN
statistical/JJ
significance/NN
was/VBD
observed/VBN
,/,
and/CC
no/DT
interaction/NN
was/VBD
found/VBN
between/IN
rs2892767/NN
and/CC
rs12110693/NN
(/(
Table/JJ
3/CD
)/)
./.
====================
These/DT
results/NNS
further/RB
validate/NN
that/DT
the/DT
2/CD
SNPs/NNS
are/VBP
independent/JJ
of/IN
each/DT
other/JJ
./.
====================
Gap/NN
junctions/NNS
are/VBP
thought/VBN
to/TO
have/VB
a/DT
crucial/JJ
role/NN
in/IN
the/DT
synchronized/JJ
contraction/NN
of/IN
the/DT
heart/NN
and/CC
in/IN
embryonic/JJ
development/NN
./.
====================
It/PRP
is/VBZ
also/RB
known/VBN
that/IN
gap/VBP
junctions/NNS
,/,
clusters/NNS
of/IN
cell-to-cell/JJ
channels/NNS
composed/VBN
of/IN
connexins/NNS
,/,
mediate/VBP
the/DT
orderly/RB
spread/VBN
of/IN
electrical/JJ
excitation/NN
throughout/IN
the/DT
heart/NN
[/(
10/CD
]/)
./.
====================
The/DT
GJA1-encoding/JJ
protein/NN
has/VBZ
been/VBN
reported/VBN
to/TO
be/VB
involved/VBN
in/IN
the/DT
development/NN
and/CC
function/NN
of/IN
the/DT
heart/NN
by/IN
allowing/VBG
direct/JJ
cell-to-cell/JJ
exchange/NN
of/IN
molecules/NNS
,/,
which/WDT
mediate/VBP
multiple/JJ
signaling/VBG
events/NNS
[/(
11/CD
]/)
./.
====================
Mutations/NNS
in/IN
GJA1/NN
cause/VBP
Mendelian/JJ
inherited/VBN
hypoplastic/JJ
left/NN
heart/NN
syndrome/NN
[/(
12/CD
]/)
./.
====================
Cho/NN
et/FW
al/JJ
./.
====================
[/(
5/CD
]/)
previously/RB
reported/VBD
the/DT
same/JJ
locus/NN
near/JJ
GJA1/NN
to/TO
be/VB
responsible/JJ
for/IN
pulse/NN
rate/NN
without/IN
evidence/NN
of/IN
replication/NN
./.
====================
In/IN
the/DT
present/JJ
study/NN
,/,
we/PRP
successfully/RB
replicated/VBN
the/DT
locus/NN
in/IN
an/DT
independent/JJ
replication/NN
study/NN
./.
====================
As/IN
indicated/VBD
from/IN
the/DT
functional/JJ
role/NN
of/IN
GJA1/NN
,/,
it/PRP
is/VBZ
a/DT
strong/JJ
candidate/NN
gene/NN
for/IN
pulse/NN
rate/NN
./.
====================
Thus/RB
,/,
further/RB
efforts/NNS
,/,
such/JJ
as/IN
fine/JJ
mapping/NN
or/CC
imputation/NN
based/VBN
on/IN
large-scale/JJ
sequencing/NN
data/NNS
near/JJ
rs2892767/NN
on/IN
6q22.31/NN
,/,
would/MD
reveal/VB
the/DT
causal/JJ
variant/JJ
of/IN
this/DT
locus/NN
./.
====================
In/IN
addition/NN
,/,
functional/JJ
studies/NNS
for/IN
GJA1/NN
would/MD
be/VB
worthwhile/JJ
to/TO
facilitate/VB
a/DT
full/JJ
understanding/NN
of/IN
its/PRP$
biological/JJ
role/NN
in/IN
pulse/NN
rate/NN
./.
====================
Our/PRP$
study/NN
was/VBD
relatively/RB
underpowered/JJ
to/TO
discover/RB
additional/JJ
novel/JJ
loci/NNS
and/CC
demonstrated/VBD
that/IN
large-scale/JJ
genomewide/NN
meta-analysis/NN
comprising/VBG
hundreds/VBZ
of/IN
thousands/NNS
samples/NNS
is/VBZ
required/VBN
for/IN
understanding/VBG
the/DT
missing/JJ
heritability/NN
of/IN
pulse/NN
rate/NN
./.
====================
Characteristics/NNS
of/IN
cohorts/NNS
====================
Variants/NNS
that/DT
associate/VBP
with/IN
variation/NN
in/IN
pulse/NN
rate/NN
====================
The/DT
effect/NN
of/IN
SNP/NN
adjustment/JJ
on/IN
pulse/NN
rate/NN
====================
